Erectile Dysfunction and Diabetes Mellitus
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00134329|
Recruitment Status : Completed
First Posted : August 24, 2005
Last Update Posted : December 28, 2007
|Condition or disease||Intervention/treatment|
|Diabetes Mellitus Erectile Dysfunction||Procedure: Filling out a questionnaire on the possible occurrence of erectile dysfunction|
Male diabetic patients who attend a diabetic routine year program visit will be asked to give their voluntary permission to fill out a questionnaire on possible erectile dysfunction.
The questionnaire consists of two parts: Part 1 is the IIEF (International Index of Erectile Function) questionnaire and Part 2 is an additional questionnaire. The included patients have to fill out these questionnaires two times; once at the beginning at a diabetic year program visit and a second time one year later at the next diabetic year program consultation.
The patients will also be asked to give their permission for using their results of the routine diabetic year program for scientific research.
|Study Type :||Observational|
|Enrollment :||300 participants|
|Official Title:||Erectile Dysfunction and Diabetes Mellitus|
|Study Start Date :||May 2005|
|Actual Study Completion Date :||March 2007|
- Documentation of the prevalence of erectile dysfunction in the diabetic convention
- Increase the awareness of diabetologist for erectile dysfunction
- Relation of erectile dysfunction with metabolic parameters
- Relation of erectile dysfunction with sex steroids
- Adjustment of the systematic follow-up of diabetic complications.
- Optimalisation of the healthcare for diabetic patients, so that the quality of life for male diabetic patients can be improved
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00134329
|University Hospital Ghent|
|Ghent, Belgium, 9000|
|Principal Investigator:||Guy T'Sjoen, MD||University Hospital, Ghent|